KEY-T 0.18 BIP.UN-T -0.15 POW-T -0.1 BBD.B-T 1.53 UNH-N -5.61 NTR-T 0.52 TGT-N 1.27
Protech Home Medical Corp (PTQ-X)
The ultimate 360° Tracker Your financial life in one place, automatically

Protech Home Medical Corp (PTQ-X)

NEW AI Investor Insights
104 watching

CVE:PTQ

2.06
0.11 (5.07%) 1d
May 12, 2021, 7:59 pm
0

Related posts

Nervous markets await Nvidia
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

May 13, 2021
(A Top Pick May 29/20, Up 55%) Oxygen delivery. Recurring revenue model. Very strong outlook.
Robert McWhirterRobert McWhirter
No
Unlock Rating
N/A

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

May 11, 2021
(A Top Pick May 27/20, Up 65%) They plan on changing their name and moving onto the Nasdaq. They fly under the radar but trade at an attractive valuation. He's sticking with this. It will continue to do well on the Nasdaq.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$2.000

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Protech Home Medical Corp(PTQ-X)

Mar 25, 2021
US focused. Lifts, supports, oxygen services. They've been acquirers. Brought debt down, increased profit margin, grown geographically. Still very attractively valued compared to its peers. Could be a takeover target.
Bruce Campbell (2)Bruce Campbell (2)
Unknown
Unlock Rating
$2.070

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Protech Home Medical Corp(PTQ-X)

Sep 01, 2020
A US company that's consolidating in the medical market (home lifts, ventilators, oxygen, etc.). He continues to like it. It was a past pick and since they made an acquisition. The stock has increased, though not as much as he expected. He predicts the valuation will be pretty attractive. This could be a takeover target and it's firing on all cylinders.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$1.250

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Protech Home Medical Corp(PTQ-X)

Jul 02, 2020
It continues to stay in this valuation range. They are in the home medical business. They operate in ten states and have 40 locations. It is a fragmented industry. They have 68% recurring revenue. They have a huge opportunity to consolidate. They can grow through valuation multiple growth and organically. (Analysts’ price target is $2.36)
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$1.130

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Protech Home Medical Corp(PTQ-X)

May 29, 2020
A perfect stock even though it is up 50% off the lows. They can service the debt and earnings expected to grow by 133%. Yield 0% (Analysts’ price target is $2.36)
Robert McWhirterRobert McWhirter
No
Unlock Rating
$1.270

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Protech Home Medical Corp(PTQ-X)

May 27, 2020
They are taking advantage of in-home health care during the pandemic. It trades at about a third of their peers, yet growth has been 20% per year. They focus on an area of the medical space that will get head winds from COVID. It will likely be taken out sometime later this year. Yield 0% (Analysts’ price target is $2.36)
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$1.060

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Protech Home Medical Corp(PTQ-X)

Apr 27, 2020
This is one that a piece of their business benefits from COVID. Oxygen sales, sleep apnea, as people get released FROM COVID hospitalization, they can get onto home ventilators. He likes it. It was a past top pick.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.800

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

Feb 13, 2020

(A Top Pick Jan 30/19, Down 4%) He would have expected it to do more. He is quite confident going forward. He thinks they will get taken out within 18 months. Almost made it a top pick again.

Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.920

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Protech Home Medical Corp(PTQ-X)

Dec 30, 2019

They had a cyber theft – 9 Million out of there bank but insurance covered it. He likes it. It is speculative and is a roll up strategy.

James HodginsJames Hodgins
No
Unlock Rating
$0.920

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

Dec 09, 2019
(A Top Pick Dec 12/18, Up 41%) It continues to grow organically and by acquisition. It is very attractive at less than 8 times earnings, which are growing at 12-15% per year. It will either get recognized by the market or get taken out.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.990

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Protech Home Medical Corp(PTQ-X)

Aug 09, 2019

They've recently announced they had a cyber attack and lost $9 million but they should get most of it back. They'll be then able to go do more mergers and acquisitions after, which should be in September. The valuation is very attractive, and it should bounce up when they make the press release that they have recovered their funds.

Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.790

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Protech Home Medical Corp(PTQ-X)

May 01, 2019
In the U.S. healthcare business. They have transformed in the past year, raising profit margins and accounts receivable. They are highly profitable around 20%. Trades at less than 10x 2020's EBITDA. Management continues to execute, doing small acqusitions.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$1.010

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Protech Home Medical Corp(PTQ-X)

Jan 30, 2019
They just released earnings this week and they have been turning their business around -- increasing margins and growing organically. Management owns about 18% of the shares and it trades at 5 times earnings. He thinks it could trade at twice that level. They are involved in patient home monitoring. Yield 0% (Analysts’ price target is $3.00)
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.960

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 14 of 14 entries
  • «
  • ‹
  • 1
  • ›
  • »

Protech Home Medical Corp(PTQ-X) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Protech Home Medical Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Protech Home Medical Corp(PTQ-X) Frequently Asked Questions

What is Protech Home Medical Corp stock symbol?

Protech Home Medical Corp is a Canadian stock, trading under the symbol PTQ-X on the TSX Venture Exchange (PTQ-CV). It is usually referred to as TSXV:PTQ or PTQ-X

Is Protech Home Medical Corp a buy or a sell?

In the last year, there was no coverage of Protech Home Medical Corp published on Stockchase.

Is Protech Home Medical Corp a good investment or a top pick?

Protech Home Medical Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Protech Home Medical Corp.

Why is Protech Home Medical Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Protech Home Medical Corp worth watching?

0 stock analysts on Stockchase covered Protech Home Medical Corp In the last year. It is a trending stock that is worth watching.

What is Protech Home Medical Corp stock price?

On 2021-05-12, Protech Home Medical Corp (PTQ-X) stock closed at a price of $2.06.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

CLS-T -3.91$123.45
NVDA-Q 4.58$111.01
PEP-Q -1.93$133.38
IBM-N 3.08$232.41
RMD-N -0.22$235.88

Today's Top Picks

KEY-T 0.18$42.62
BIP.UN… -0.15$39.97
POW-T -0.1$50.8
BBD.B-… 1.53$91.21
UNH-N -5.61$418.64

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

ARE-T -0.27$15.4
CVX-N -0.34$138.73
XOM-N -0.06$108.57
CNQ-T -0.01$40.68
TD-T -0.03$86.17

Most Recent Experts

Greg Newman

Scotia Wealth Management

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

© Stockchase Inc.